// App-Quantinova.ai

8 : Impact of therapy on gene expression in high-risk prostate cancer (PCA) treated with neoadjuvant docetaxel and androgen deprivation therapy.

Researchers

Presenter

  • Himisha Beltran

Principal Investigators

  • Alexander Wyatt

  • Edmund Chedgy

  • Ladan Fazli

  • Andrea Sboner

  • Susan Halabi

  • Martin Gleave

Medical Centers

  • Weill Cornell Medical College, New York, NY

  • Vancouver Prostate Centre, Vancouver, BC, Canada

  • Department of Medicine, Institute for Precision Medicine, Department of Pathology and Laboratory Medicine

  • Institute for Computational Biomedicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY

  • Duke University Medical Center, Durham, NC

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Solute Carrier Family 22 Member 3

Drug/Treatment

  • Docetaxel

  • Androgen Tear

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • NCT00430183

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved